Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group.

Teeter AE, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ.

Urology. 2013 Jul;82(1):53-8. doi: 10.1016/j.urology.2012.10.090.

2.

Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.

Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco FJ Jr, Rabah DM, Klein EA, Ciezki JP, Gao T, Kattan MW, Stephenson AJ.

Eur Urol. 2015 Jun;67(6):1160-7. doi: 10.1016/j.eururo.2014.09.019. Epub 2014 Oct 6.

3.

Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases.

Moreira DM, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Sun LL, Moul JW, Freedland SJ.

Int J Urol. 2010 Nov;17(11):914-22. doi: 10.1111/j.1442-2042.2010.02631.x. Epub 2010 Sep 30.

4.

Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.

Lee BH, Kibel AS, Ciezki JP, Klein EA, Reddy CA, Yu C, Kattan MW, Stephenson AJ.

Eur Urol. 2015 Feb;67(2):204-9. doi: 10.1016/j.eururo.2014.09.017. Epub 2014 Oct 5.

PMID:
25294696
5.

Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy.

Schroeck FR, Kattan MW, Moul JW, Aronson WJ, Presti JC Jr, Terris MK, Kane CJ, Amling CL, Sun L, Freedland SJ.

BJU Int. 2010 Jun;105(12):1654-9. doi: 10.1111/j.1464-410X.2009.09060.x. Epub 2009 Nov 13.

6.

Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone?

Schroeck FR, Aronson WJ, Presti JC Jr, Terris MK, Kane CJ, Amling CL, Freedland SJ.

BJU Int. 2009 Mar;103(5):603-8. doi: 10.1111/j.1464-410X.2008.08118.x. Epub 2008 Nov 18.

7.

External validation of preoperative nomograms predicting biochemical recurrence after radical prostatectomy.

Tanaka A, Ohori M, Paul L, Yu C, Kattan MW, Ohno Y, Tachibana M.

Jpn J Clin Oncol. 2013 Dec;43(12):1255-60. doi: 10.1093/jjco/hyt154. Epub 2013 Oct 21.

8.

Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.

Mithal P, Howard LE, Aronson WJ, Kane CJ, Cooperberg MR, Terris MK, Amling CL, Freedland SJ.

Int J Urol. 2015 Apr;22(4):362-6. doi: 10.1111/iju.12704. Epub 2015 Feb 24.

9.

Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy.

Briganti A, Karnes RJ, Joniau S, Boorjian SA, Cozzarini C, Gandaglia G, Hinkelbein W, Haustermans K, Tombal B, Shariat S, Sun M, Karakiewicz PI, Montorsi F, Van Poppel H, Wiegel T.

Eur Urol. 2014 Sep;66(3):479-86. doi: 10.1016/j.eururo.2013.11.045. Epub 2013 Dec 12.

PMID:
24345725
10.

Impact of international variation of prostate cancer on a predictive nomogram for biochemical recurrence in clinically localised prostate cancer.

Cho YM, Jung SJ, Cho N, Kim MJ, Kattan MW, Yu C, Ahn H, Ro JY; Genitourinary Pathology Study Group of the Korean Society of Pathologists.

World J Urol. 2014 Apr;32(2):399-405. doi: 10.1007/s00345-013-1111-6. Epub 2013 Jun 14.

PMID:
23765315
11.

Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.

Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane CJ, Carroll PR.

J Urol. 2005 Apr;173(4):1126-31.

PMID:
15758720
12.

Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.

Tamblyn DJ, Chopra S, Yu C, Kattan MW, Pinnock C, Kopsaftis T.

BJU Int. 2011 Nov;108 Suppl 2:51-6. doi: 10.1111/j.1464-410X.2011.10687.x.

13.

The Shared Equal Access Regional Cancer Hospital (SEARCH) nomogram for risk stratification in intermediate risk group of men with prostate cancer: validation in the Duke Prostate Center database.

Jayachandran J, Schroeck F, Sun L, Gerber L, Moreira DM, Moul JW, Freedland SJ.

BJU Int. 2010 Jan;105(2):180-4. doi: 10.1111/j.1464-410X.2009.08728.x. Epub 2009 Aug 25.

14.

A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.

Graefen M, Karakiewicz PI, Cagiannos I, Hammerer PG, Haese A, Palisaar J, Fernandez S, Noldus J, Erbersdobler A, Huland H, Scardino PT, Kattan MW.

Urol Oncol. 2002 Jul-Aug;7(4):141-6.

PMID:
12474529
15.
16.

Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy.

Punnen S, Freedland SJ, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Carroll PR, Cooperberg MR.

Eur Urol. 2014 Jun;65(6):1171-7. doi: 10.1016/j.eururo.2013.03.058. Epub 2013 Apr 8.

PMID:
23587869
17.

The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.

Moreira DM, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Sun LL, Moul JW, Freedland SJ.

Prostate Cancer Prostatic Dis. 2010 Mar;13(1):87-93. doi: 10.1038/pcan.2009.48. Epub 2009 Nov 17.

18.

Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database.

Moreira DM, Jayachandran J, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Stephenson AJ, Freedland SJ.

BJU Int. 2009 Nov;104(10):1452-6. doi: 10.1111/j.1464-410X.2009.08623.x. Epub 2009 May 18.

19.

Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.

Rouprêt M, Hupertan V, Comperat E, Drouin SJ, Phé V, Xylinas E, Demanse D, Sibony M, Richard F, Cussenot O.

BJU Int. 2009 Sep;104(6):813-7; discussion 817-8. doi: 10.1111/j.1464-410X.2009.08473.x. Epub 2009 Feb 27.

20.

Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy.

Yates DR, Rouprêt M, Drouin SJ, Comperat E, Ricci S, Lacave R, Sèbe P, Cancel-Tassin G, Bitker MO, Cussenot O.

Prostate. 2012 Sep 1;72(12):1382-8. doi: 10.1002/pros.22488. Epub 2012 Jan 6.

PMID:
22228175
Items per page

Supplemental Content

Write to the Help Desk